Raymond C. Bergan
Affiliations: | Integrated Graduate Program in the Life Sciences | Northwestern University, Evanston, IL |
Area:
Biochemistry, Oncology, General BiophysicsGoogle:
"Raymond Bergan"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Clarissa S. Craft | grad student | 2007 | Northwestern |
| Sankar N. Krishna | grad student | 2014 | Northwestern |
| Janet M. Pavese | grad student | 2014 | Northwestern |
| Eric A. Voll | grad student | 2014 | Northwestern |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gironda DJ, Bergan RC, Alpaugh RK, et al. (2023) Cancer Associated Macrophage-like Cells Are Prognostic for Highly Aggressive Prostate Cancer in Both the Non-Metastatic and Metastatic Settings. Cancers. 15 |
| Johnson BE, Creason AL, Stommel JM, et al. (2022) An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer. Cell Reports. Medicine. 3: 100525 |
| Labrie M, Li A, Creason A, et al. (2021) Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies. Npj Precision Oncology. 5: 92 |
| Graff JN, Beer TM, Alumkal JJ, et al. (2020) A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone. Journal For Immunotherapy of Cancer. 8 |
| Zhang X, Zhang Z, Cao M, et al. (2020) A Randomized Parallel Controlled Phase II Trial of Recombinant Human Endostatin Added to Neoadjuvant Chemotherapy for Stage III Breast Cancer. Clinical Breast Cancer |
| Li A, Labrie M, Vuky J, et al. (2020) Feasibility of real-time serial comprehensive tumor analytics: Pilot study of olaparib and durvalumab in metastatic triple negative breast cancer (mTNBC). Journal of Clinical Oncology. 38: e13092-e13092 |
| Adams D, Lin SH, Pass HI, et al. (2020) Circulating stromal cells as a potential blood-based biomarker for screening invasive solid tumors. Journal of Clinical Oncology. 38: 3535-3535 |
| Zhang Z, Bien J, Mori M, et al. (2019) A way forward for cancer prevention therapy: personalized risk assessment. Oncotarget. 10: 6898-6912 |
| Bergan R, Xu L, Zhang Y, et al. (2019) A Phase I Trial of Berberine in Chinese with Ulcerative Colitis. Cancer Prevention Research (Philadelphia, Pa.) |
| Zhang L, Pattanayak A, Li W, et al. (2019) A multi-functional therapy approach for cancer: targeting Raf1- mediated inhibition of cell motility, growth and interaction with the microenvironment. Molecular Cancer Therapeutics |